CANNAINVESTOR Magazine November / December 2016 - Page 34


Investment Highlights

• Uniquely positioned company within the

large and growing medical and recreational

marijuana industry

• Clear strategy across three verticals of marijuana

production, patient education,

and pharmaceutical production

• High quality experienced management

team who have aligned interests with

shareholders by investing $6MM, and a track

record of building successful multi-billion

dollar companies

• State of the art production facility in Paris,

Ontario in operation with first sales acheived

in August, 2016

• Expansion capacity allowing a total annual

production of 21,000KG